Fountain Centers of Rochester
Treatment Center Details
Tap on any of the following links to see detailed information on what this facility offers.
Payment
Payment Accepted
Military insurance (e.g., TRICARE)
Private health insurance
Cash or self-payment
State-financed health insurance plan other than Medicaid
Treatment Services
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
Type of Opioid Treatment
Prescribes buprenorphine
Administers naltrexone
Accepts clients on opioid medication but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®)
Disulfiram (Antabuse®)
Buprenorphine sub-dermal implant (Probuphine®)
Buprenorphine with naloxone (Ex. Suboxone®)
Buprenorphine without naloxone
Buprenorphine (extended-release, injectable, for example, Sublocade®)
Naltrexone (oral)
Naltrexone (extended-release, injectable naltrexone (Vivitrol®)
Medications for psychiatric disorders
Special Programs
Adolescents
Persons with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive substance use assessment
Transitional Services
Aftercare/continuing care
Discharge Planning
Naloxone and overdose education
Tobacco/Screening Services
Nicotine replacement therapy
Non-nicotine smoking/tobacco cessation medications
Screening for tobacco use
Facility Details
Service Settings
Outpatient
Intensive outpatient treatment
Regular outpatient treatment
External Opioid Medications Source
In-network prescribing entity
Personal physician/health care provider
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Personal physician/health care provider
Facility Operation
Private non-profit organization
Patient Accommodations
Ancillary Services
Case management
Mental health services
Recovery coach
Social skills development
Mentoring/peer support/consumer-run services
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Children/adolescents
Gender Accepted
Female
Male